James Greenwood, BIO CEO
Listen now
Description
James Greenwood, BIO president & CEO, talks about drug pricing & the legislation (H.R. 3) that House Democrats are planning, as well as Senate plans. Speaker Nancy Pelosi highlighted House drug-pricing plans this week.
More Episodes
Published 03/22/20
AFL-CIO President Richard Trumka talks about the coronavirus’s impact on American workers and what he expects ahead. He talks about the U.S. economy more widely as well, labor’s relationship with Congress and the Administration, and presidential politics.
Published 03/22/20
The top Republican on the Energy and Commerce Committee, Rep. Greg Walden, talks about Congress’s and the Administration’s response to the coronavirus outbreak. He discusses the $2 trillion stimulus package and his belief the Administration is doing well.
Published 03/22/20